Psychologists in York, ME Accepting Medicare
7 Psychologists found. Showing 1 - 7
 Ms. Alice Marie Gruba, MSW, MS SCHOOL PSYCH Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 186 Southside Rd, York, ME 03909 Phone: 207-890-5692 |
Sandra Deacon Carr, PHD Psychologist - Counseling Medicare: Not Enrolled in Medicare Practice Location: 36 Old East Scituate Rd, York, ME 03909 Phone: 207-363-5785 |
Linda C Monahon, PHD Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 433 Us Route 1, Cottage Place #205, York, ME 03909 Phone: 207-363-6535 |
Dr. Kari Primo-liddy, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 433 Us Route 1, Suite 110, York, ME 03909 Phone: 207-363-0565 |
Dr. Kerry E. Hoag, PSY.D. Psychologist Medicare: Medicare Enrolled Practice Location: 192 York St, York, ME 03909 Phone: 207-450-9002 |
Constance Hanley, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 192 York St, York, ME 03909 Phone: 207-363-2164 Fax: 207-363-7808 |
 Dr. Thomas Roy Moyer, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 647 Us Route 1, York, ME 03909 Phone: 207-363-7142 Fax: 207-363-3309 |
News Archive
Study investigates role of inflammation in ALS mouse model
Amyotrophic lateral sclerosis (ALS) is a progressive disease wherein the cells of the central nervous system (CNS) involved in movement and coordination are destroyed. Although the mechanism of ALS is not completely understood, inflammation is believed to play a role in the disease process. A recent study by Howard Weiner and colleagues at Harvard Medical School and Tufts School of Medicine investigated the role of inflammation in a mouse model of ALS.
New way of monitoring blood pressure wins innovation and technology award
Revolutionary device developed by University of Leicester, in collaboration with biotech SME HealthStats in Singapore and the NHS, wins Times Higher Education Award.
Emerging pharmacologic approach may inhibit NASH
Treating a liver disease called NASH (non-alcoholic steatohepatitis), which affects 10 to 15 percent of obese individuals with type-2 diabetes worldwide, is difficult. But now scientists believe they have found a pharmacologic approach that may inhibit NASH, and thus stop deadly conditions that result from NASH such as cirrhosis and liver cancer.
BioAlliance Pharma wins first prize in Deloitte's Technology Fast 50 2009
BioAlliance Pharma SA, a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announced that it has won first prize in Deloitte's Technology Fast 50 2009TM ranking of France's fastest-growth technology companies.
› Verified 3 days ago
Pharmacists
Clinical Social Workers
Counselors
Occupational Therapists
Psychologists
Dentists